CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-07 | Mirza Mansoor Raza Director | Sale | −5,000 | $16.04 | $80K | 5,000 |
| 2020-12-07 | Mirza Mansoor Raza Director | Sale | −5,000 | $16.14 | $81K | 0 |
| 2020-12-07 | Mirza Mansoor Raza Director | Exercise or conversion · Stock Option (right to buy) | −20,000 | 5,000 | ||
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +78,124 | $10.45 | $816K | 82,647 |
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −78,124 | $17.66 | $1.4M | 4,523 |
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +58,937 | $10.39 | $612K | 63,460 |
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −58,937 | $17.35 | $1.0M | 4,523 |
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −78,124 | 46,876 | ||
| 2020-12-01 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −58,937 | 16,842 | ||
| 2020-11-25 | Schor Chen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +32,800 | 32,800 | ||
| 2020-11-02 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −772 | $14.92 | $12K | 4,523 |
| 2020-10-30 | Lewis Tanya EVP,Chief Reg.&Quality Officer | Sale | −226 | $15.58 | $4K | 539 |
| 2020-10-28 | Lewis Tanya EVP,Chief Reg.&Quality Officer | Exercise or conversion | +765 | 765 | ||
| 2020-10-28 | Lewis Tanya EVP,Chief Reg.&Quality Officer | Exercise or conversion · Restricted Stock Units | −765 | 2,295 | ||
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +38,550 | $9.21 | $355K | 43,199 |
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −38,550 | $16.85 | $650K | 4,649 |
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +721 | $10.39 | $7K | 5,370 |
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −721 | $17.20 | $12K | 4,649 |
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −38,550 | 64,250 | ||
| 2020-10-13 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −721 | 75,779 |
Page 20 of 29 · 570 trades